The Use of Long-Acting Lipoglycopeptides for the Treatment of Serious, Off-label Infections: a Review of the Literature

被引：0
|
作者：
Zachary P. Gruss
Tyler Baumeister
Jordan Smith
机构：
[1] Wake Forest Baptist Medical Center,Department of Pharmacy
[2] Department of Pharmacy,Fred Wilson School of Pharmacy
[3] Moses Cone Hospital,undefined
[4] High Point University,undefined
来源：
Current Infectious Disease Reports | 2021年 / 23卷
关键词：
Long-acting lipoglycopeptides; Dalbavancin; Oritavancin; Bone and joint infections; Infective endocarditis; Injection drug use;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections:: Case series and review of the literature
    Ruhe, JJ
    Monson, T
    Bradsher, RW
    Menon, A
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (10) : 1429 - 1434
  • [32] Off-label Use of Long-Acting Injectable Antiretroviral Therapy: A Single Center Retrospective Review of Youth Living With HIV With Detectable HIV RNA Starting Injectable Therapy
    Rousseau, Alison
    McGrath, Eric
    Benjamins, Laura
    Cockern, Salome
    Meade, Jill
    Houston, Keshaum
    Breaux, Melina
    Secord, Elizabeth
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2024, 13 (05) : 285 - 287
  • [33] Off-label use of intravenous immunoglobulin therapy in the treatment of lupus myocarditis: Two case reports and literature review
    Charhon, N.
    Bernard, C.
    Richard, J. C.
    Cordel, N.
    Leboucher, G.
    Broussolle, C.
    Seve, P.
    REVUE DE MEDECINE INTERNE, 2017, 38 (03): : 204 - 209
  • [34] Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature
    M. Bevacqua
    F. Baldo
    S. Pastore
    E. Valencic
    Alberto Tommasini
    A. Maestro
    M. Rabusin
    A. Arbo
    E. Barbi
    Pediatric Drugs, 2019, 21 : 185 - 193
  • [35] Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature
    Chedid, T.
    Moisset, X.
    Clavelou, P.
    REVUE NEUROLOGIQUE, 2022, 178 (09) : 932 - 938
  • [36] Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature
    Bevacqua, M.
    Baldo, F.
    Pastore, S.
    Valencic, E.
    Tommasini, Alberto
    Maestro, A.
    Rabusin, M.
    Arbo, A.
    Barbi, E.
    PEDIATRIC DRUGS, 2019, 21 (03) : 185 - 193
  • [37] Extent and outcomes of off-label drug use in oncology practice: a systematic review of literature
    Saiyed, M. M.
    Ong, P. S.
    Chew, L.
    ANNALS OF ONCOLOGY, 2015, 26 : 157 - 157
  • [38] Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature
    Zarkali, Angeliki
    Karageorgopoulos, Drosos E.
    Rafailidis, Petros I.
    Falagas, Matthew E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (03) : 471 - 480
  • [39] Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
    Fischler, Pascal Valentin
    Soyka, Michael
    Seifritz, Erich
    Mutschler, Jochen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Off-label use of hormones as an antiaging strategy: a review
    Samaras, Nikolaos
    Papadopoulou, Maria-Aikaterini
    Samaras, Dimitrios
    Ongaro, Filippo
    CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 1175 - 1186
12345